Amneal Pharmaceuticals’ first quarter results were met with a negative reaction from the market, reflecting revenue that ...

Pursue advocacy efforts We’ve seen critical legal decisions over the last five years either accelerate or stymie the United States biosimilar market. In the 2017 Amgen v. Sandoz case, the ...

Without biosimilar medicines in the market, the competitive pressure to keep prices low disappears, and with it the access benefits and cost savings that patients and healthcare systems rely on.

The Myth of Fingerprints Police today increasingly embrace DNA tests as the ultimate crime-fighting tool. They once felt the same way about fingerprinting Clive Thompson April 2019 ...

Medical news, education and information for physicians and health care professionals, presented by specialty and topic. From Healio and the Wyanoke Group.